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Abstract
Cholangiocarcinoma (CC) arises from the biliary epithelium and in most cases represents adenocarcinoma. Pathomor-
phological evaluation is of decisive impact for the prognosis and management of CC. Morphological subtyping (histotype;
hilar vs peripheral type), TNM classification, lymphatic spread, and resection margin status are of prognostic relevance.
Distinction from hepatic metastases may be aided by immunohistology and clinico-pathological correlation. There is
convincing evidence of the development of CC via premalignant lesions, especially biliary intraepithelial neoplasia, although
further knowledge about the biology and diagnostic definition of these lesions has to be accumulated. Currently, there are
no established molecular markers of prognosis or therapeutic target structures to be evaluated at the tissue level. Future
progress is needed and expected in novel differential diagnostic and predictive markers, in uniform definition of resection
margin status and further understanding of molecular and morphological changes in the development of CC.
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Introduction
Bile duct cancer (cholangiocarcinoma (CC)) accounts
for about 3% of all gastrointestinal cancers with a
dismal long-term survival of 3.5% [1]. It arises from
the ductal epithelium of the biliary tree. Depending
on its location, it is classified into intrahepatic (ICC)
or extrahepatic (ECC) CC, the latter being subclassi-
fied into proximal, middle, and distal subgroups. A
three-tiered classification system into intrahepatic,
perihilar (defined as a tumor located in the extra-
hepatic biliary tree proximal to the origin of the cystic
duct), and distal CC seems more appropriate, how-
ever, since it correlates with anatomical distribution,
preferred surgical treatment, and resectability rates
[2]. According to this classification, perhilar tumors
occur most frequently, followed in order by the
extrahepatic distal and intrahepatic types [3].
Macroscopically, CC is usually a firm to hard, white
to tan-white mass without extensive necrosis. ICC can
form a single mass with or without satellite nodules, in
most cases not accompanied by cirrhosis. Less fre-
quently, it consists of multiple nodules [4]. Japanese
authors have distinguished two macroscopical growth
patterns of ICC  ‘‘mass forming’’ and ‘‘periductal
infiltrating’’ types [5]  which largely corresponds to
ICC being classified into peripheral and hilar tumors,
depending on their origin from small or large intra-
hepatic biliary ducts [6]. Both hilar and peripheral
ICC have been related to different premalignant
conditions, progression features, and prognoses [7].
ICC usually attains a larger size than perhilar and
distal ECC, probably as a consequence of later onset
of symptoms: in a large recently reported series of 564
patients, the median diameter of ICC was 5.5 cm
versus 2.5 cm and 2 cm of perihilar and distal tumors,
respectively [3]. Perihilar ECC can cause segmental
atrophy of the liver, leading to radiological over-
estimation of the tumor size, which can affect resect-
ability assessment. ECC usually displays a periductal
infiltrating growth or appears as polypoid indurated
masses [8]. Depending on its primary site of origin,
ECC may extend to the liver, gallbladder, pancreas,
ampulla, or duodenum. Since all these organs them-
selves may give rise to carcinomas with similar
morphological features, identification of the exact
origin relies on precise macroscopy but may be
impossible in larger tumors, even after careful clin-
icopathologic correlation.
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Microscopically, classic CCs are adenocarcinomas
consisting of tubules, acini, solid nests, or trabeculae,
usually embedded in a desmoplastic stroma. The
tumor cells typically express cytokeratins 7 and 19,
epithelial membrane antigen, BER-EP4, and display a
cytoplasmic positivity for carcinoembryonic antigen
(CEA). The absence of a membrane staining for
polyclonal CEA and hepatocyte antigen (Hep Par 1)
aids in distinguishing ICC from hepatocellular carci-
noma (HCC) with pseudoglandular pattern [9]. In-
vasive papillary CCs show different morphological,
immunhistological, and clinical/prognostic character-
istics compared with classical CCs [10] and belong to
the spectrum of biliary papillary tumors (see below).
Histological variants of CC other than papillary
adenocarcinomas are altogether rare (less than 10%)
and include mucinous and signet ring cell carcinomas
characterized by large amounts of extra- and intracel-
lular mucin, adenosquamous carcinomas, squamous
cell carcinomas, probably arising from metaplastic
squamous epithelium and usually associated with
solitary liver cysts [11], mucoepidermoid carcinomas,
glycogen-rich clear cell carcinomas, and spindle cell/
undifferentiated carcinomas. The adenosquamous and
spindle cell variants appear to have a worse prognosis
than classical adenocarcinomas [1214]. A rare type of
ICC with a better prognosis than the classical type is
the so-called hepatobiliary cystadenocarcinoma, a
papillary adenocarcinoma usually arising in a multi-
locular cystadenoma or in a unilocular bile duct cyst
[15]. In female patients, the stroma of cystadenocarci-
nomas and of their benign counterparts (hepatobiliary
cystadenomas) is densely cellular (‘‘ovarian-like’’).
This fact, together with the expression of hormone
receptors in the stromal cells, has suggested an origin
from ectopic Mullerian epithelium [16].
ICC should be distinguished from HCC with
pseudoglandular pattern (discussed above) and meta-
static adenocarcinoma. Organ-specific antigens (e.g.
PSA, TTF-1, CDX-2, hormone receptors) may aid in
some cases in the differentiation of ICC from meta-
static adenocarcinoma, but distinction also relies on
the clinical exclusion of an extrahepatic primary
tumor. Combined HCC-CC is characterized by un-
equivocal cholangiolar (e.g. mucin production) and
unequivocal hepatocellular differentiation and is con-
sidered a special subtype of HCC [4]. ECC has to be
distinguished from reactive/inflammatory conditions,
as in primary or secondary sclerosing cholangitis. This
can be difficult and sometimes impossible in small
biopsies of well-differentiated lesions. Preservation of
the lobular arrangement of the glands, strong inflam-
matory background, less pronounced nuclear hyper-
chromatism and epithelial atypia favor a benign
process, whereas the presence of perineural infiltration
almost always indicates malignancy. p53 overexpres-
sion has been suggested as an additional criterion of
malignancy in the differential diagnosis between ECC
and reactive epithelial atypia, but is not thoroughly
evaluated and currently not a standard diagnostic
criterion [17].
Premalignant/preinvasive lesions of the biliary tree
belong to two different subgroups: biliary intraepithe-
lial (BilIN) and biliary intraductal papillary neoplasia
(biliary IPN). BilINs are a group of flat, pseudopa-
pillary, or micropapillary lesions classified by a recent
international consensus into three categories (grades)
based on the degree of atypia: BilIN-1, BilIN-2, and
BilIN-3, this last-mentioned also including carcinoma
in situ [18]. Since BilINs share morphology and
expression patterns of mucin core proteins (MUC1
and MUC2) with pancreatic intraepithelial neoplasia
(PanIN) [19], it has been suggested that they repre-
sent the counterpart of PanIN [18]. Biliary IPNs are
grossly visible, non-invasive, intraductal papillary
proliferations and resemble pancreatic intraductal
papillary mucinous neoplasms (IPMN) [20]. Biliary
IPNs, including biliary papillomatosis, show macro-
scopic mucinous hypersecretion in about 30% of cases
and may display three different forms of differentia-
tion: pancreaticobiliary, intestinal, and gastric. When
invasive, they can display a tubular or mucinous
pattern, the former bearing a worse prognosis [10].
Biliary papillary carcinomas have a more favorable
prognosis than classical non-papillary adenocarcino-
mas, with a 5-year survival rate of 22% versus 8%,
respectively [8].
The modes of spread of CC include perineural
infiltration, described in 39% of patients with ICC
[21] and in up to 75% of patients with ECC [22], as
well as lymphatic permeation and venous invasion,
seen in 61% and 64% of patients with ICC [21], in
50% and 38% of patients with upper bile duct cancer,
and both in 73% of patients with lower bile duct
cancer [22]. These factors have been associated with
a worse prognosis of bile duct cancer, mostly at
univariate analysis, in different surgical series
[23,24]. Perihilar and distal CCs frequently spread
by direct extension into the surrounding soft tissues
and along the wall of the bile ducts. Lymph node
metastases have been reported in 47% of resected
CC. In this series of 564 patients, a larger proportion
of distal cancers (60%) had positive locoregional
lymph nodes compared with perihilar (28%) and
intrahepatic (29%) cancers [3]. The most frequently
involved lymph node stations in cases of distal CCs
are the posterior-superior pancreatico-duodenal, the
pericholedochal and those around the mesenteric
artery [25]. Positive lymph nodes usually represent a
prognostic relevant factor in uni- and multivariate
analyses [3,21,23,26]. Distant metastases have been
described in up to 70% of patients; diffuse peritoneal
seeding usually occurs late as a result of local
recurrence [8].
According to the UICC (International Union
Against Cancer) TNM rules, ICC (together with
HCC) is classified as ‘‘liver tumor’’, resulting in a
different staging system compared to that used for
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ECC [27]. The assessment of tumor differentiation
(grading), however, has to follow the general four-
tiered UICC or alternatively the three-tiered World
Health Organization classification [28] for both ICC
and ECC, since the specific UICC grading guideline
for liver tumors is not applicable to ICC.
Obtaining negative margins (R0) at resection re-
presents an important prognostic factor in all sub-
groups of CC, as shown in all large surgical series
[2,3,26,29]. Perihilar CC has the lowest R0 rates
compared to ICC or distal ECC, although the
performance of a partial hepatic resection together
with the bile duct resection seems to increase the
number of curative resections [3,29]. Some studies
have suggested that only invasive carcinoma and not
carcinoma in situ at the bile duct resection margin
significantly affects the survival of patients with hilar
and/or distal ECC [26,30]. The relevance of the radial
margin status in extrahepatic CC has been under-
scored by others [31]. However, the criteria for the
definition of R1 resections are not univocal: for
example, Japanese authors require a distance of
5 mm to define R0 resections [21,32], whereas in
Western countries usually no recommendation is
given, so that only the presence of a tumor at the
resection margins is considered to define R1 (see, for
example, the recommendations of the College of
American Pathologists at www.cap.org). Moreover,
examination of the resection margin  at least for hilar
and distal ECC  is usually performed intraopera-
tively, with the lower quality of frozen sections surely
impairing the evaluation of parameter, such as the
presence of dysplasia/carcinoma in situ and their
differentiation from reactive changes. Since a curative
resection is one of the most robust prognostic factors
for CC, larger studies are surely needed to obtain an
international consensus for the pathological examina-
tion of surgical specimens with CC.
Consensus statements
. Cholangiocarcinoma (CC) arises from the
epithelium of the biliary tract and in most cases
represents adenocarcinoma. Morphological sub-
typing of CC is relevant for differential diagnosis
and bears some prognostic impact.
. Subtyping of CC according to location is relevant
in regard to prognosis and therapy and partly
correlates to macroscopic and microscopic tumor
morphology. It has not been performed in a
uniform manner, but the majority of data favor a
distinction of peripheral intrahepatic, (peri)hilar,
and distal (extrahepatic) CC.
. Differential diagnosis of CC versus metastases or
non-malignant conditions requires clinico-patho-
logical correlation and is aided by immunohistol-
ogy.
. TNM classification according to UICC differs
for intra- and extrahepatic CC. For tumor
grading, the general four-step UICC or the
three-step WHO grading has to be applied.
. Assessment in operation specimen of (lympho-
glandular) spread and resection margin status is
of prognostic relevance, although the definition
of the R-status has not been applied in a uniform
manner worldwide.
. Convincing evidence exists for the stepwise
development of CC via premalignant conditions.
Most cases appear to arise from biliary intrae-
pithelial neoplasia, while less frequently intra-
ductal papillary neoplasia or hepatobiliary
cystadenoma may represent alternative precursor
lesions. The frequencies and time spans required
for malignant transformation are unknown. A
consensus for a three-tiered grading (BilIN 1-3)
has been reached, although distinction of BilIN 2
is currently unsatisfactory.
. Relevant topics to be addressed in the future are:
k More specific diagnostic and prognostic
markers of CC.
k Application of a uniform topographical
classification.
k Prospective evaluation of intraepithelial neo-
plasia.
k Uniform definition of R-status and its evalua-
tion.
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